Hunan Jingfeng Pharmaceutical Co.,Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 645.32 million compared to CNY 822.56 million a year ago. Revenue was CNY 656.89 million compared to CNY 840.66 million a year ago.

Net loss was CNY 215.14 million compared to CNY 122.56 million a year ago. Basic loss per share from continuing operations was CNY 0.2445 compared to CNY 0.1393 a year ago. Diluted loss per share from continuing operations was CNY 0.2445 compared to CNY 0.1393 a year ago.